Member Log in
forgot password?
People in the developing world often go without the vaccines they need. In the first place, vaccines for the diseases that afflict it are too expensive for countries with annual health care spending of less than $10 a head. Moreover, the development of vaccines for these diseases is usually a risky and unprofitable enterprise for pharmaceuticals companies.
for all topics, visit the site map
Companies that divest during downturns may actually miss the best opportunities for growth. A thoughtful acquisition strategy can sometimes be the surer bet.
Abstract
View our privacy policy.
We will not share your e-mail. See details.
*Required